SHIM
NVAX icon

Stone House Investment Management’s Novavax NVAX Stock Holding History

Stone House Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414 Hold
44
– – ﹤0.01% 1062
2026
Q1 		$358 Hold
44
– – ﹤0.01% 867
2025
Q4 		$296 Buy
+44
New +$332 ﹤0.01% 758

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Stone House Investment Management's NVAX Position: Q2 2026 in Review

Stone House Investment Management held its Novavax (NVAX) position steady in Q2 2026 at 44 shares worth $414. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Stone House Investment Management first reported a position in NVAX in Q4 2025 and has held it in 3 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Stone House Investment Management held 44 shares of Novavax worth $414 as of Q2 2026.
  • Stone House Investment Management left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #1062 holding.
  • Stone House Investment Management first reported a position in Novavax in Q4 2025 and has held it in 3 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.